Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling

Autor: Hua Li, Udayan Apte, Maura O'Neil, Nairita Roy, Lina Sun, Bharat Bhushan, Genea Edwards, Kevin M. Beggs, Prachi Borude, Sumedha Gunewardena, Michael W. Manley, Chad Walesky
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Physiology
Liver and Biliary Tract Physiology/Pathophysiology
Apoptosis
Gastroenterology
Pathogenesis
chemistry.chemical_compound
Liver Neoplasms
Experimental

Diethylnitrosamine
Cells
Cultured

Bile acid
NF-kappa B
Middle Aged
Endoplasmic Reticulum Stress
Tumor Burden
Gene Expression Regulation
Neoplastic

Cell Transformation
Neoplastic

Hepatocellular carcinoma
Neoplastic Stem Cells
Female
Inflammation Mediators
Mitogen-Activated Protein Kinases
Signal Transduction
Adult
medicine.medical_specialty
Carcinoma
Hepatocellular

medicine.drug_class
Cholic Acid
Biology
Kruppel-Like Factor 4
Young Adult
03 medical and health sciences
SOX2
Physiology (medical)
Internal medicine
medicine
Animals
Humans
Cell Proliferation
Hepatology
Cholic acid
HCCS
medicine.disease
digestive system diseases
Mice
Inbred C57BL

IκBα
030104 developmental biology
chemistry
Hepatocytes
Cancer research
Tumor promotion
Zdroj: American Journal of Physiology-Gastrointestinal and Liver Physiology. 311:G91-G104
ISSN: 1522-1547
0193-1857
Popis: Hepatocellular carcinoma (HCC) is the most common hepatic malignancy and the third leading cause of cancer related deaths. Previous studies have implicated bile acids in pathogenesis of HCC, but the mechanisms are not known. We investigated the mechanisms of HCC tumor promotion by bile acids the diethylnitrosamine (DEN)-initiation-cholic acid (CA)-induced tumor promotion protocol in mice. The data show that 0.2% CA treatment resulted in threefold increase in number and size of DEN-induced liver tumors. All tumors observed in DEN-treated mice were well-differentiated HCCs. The HCCs observed in DEN-treated CA-fed mice exhibited extensive CD3-, CD20-, and CD45-positive inflammatory cell aggregates. Microarray-based global gene expression studies combined with Ingenuity Pathway Analysis revealed significant activation of NF-κB and Nanog in the DEN-treated 0.2% CA-fed livers. Further studies showed significantly higher TNF-α and IL-1β mRNA, a marked increase in total and phosphorylated-p65 and phosphorylated IκBα (degradation form) in livers of DEN-treated 0.2% CA-fed mice. Treatment of primary mouse hepatocytes with various bile acids showed significant induction of stemness genes including Nanog, KLF4, Sox2, and Oct4. Quantification of total and 20 specific bile acids in liver, and serum revealed a tumor-associated bile acid signature. Finally, quantification of total serum bile acids in normal, cirrhotic, and HCC human samples revealed increased bile acids in serum of cirrhotic and HCC patients. Taken together, these data indicate that bile acids are mechanistically involved pathogenesis of HCC and may promote HCC formation via activation of inflammatory signaling.
Databáze: OpenAIRE